A-O-D ninety-six-oh-four
A modified fragment of growth hormone that targets fat burning without the growth-promoting side effects of full GH.
Also known as: Anti-Obesity Drug 9604, hGH fragment 176-191
Last reviewed: April 2026
AOD-9604 is a fragment of growth hormone (amino acids 176-191) with a tyrosine modification. It retains GH's fat-burning activity but not its growth-promoting effects. It stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat creation) without affecting blood sugar or growth.
Injection into belly fat, typically morning on empty stomach
Frequency
Daily
Pain Level
●○○ Minimal
Self-Administered
Yes — at home
Typical Range
300mcg – 500mcg
Month 1–2
Subtle fat metabolism changes.
Month 3+
Body composition improvements alongside diet and exercise.
Overall: Mild
Injection site reaction
Mild redness.
• Pregnancy
• Limited human safety data
• Limited data available
Pregnancy: Not studied in pregnancy. Avoid.
Targets fat metabolism directly. Unlike GLP-1 agonists (appetite), AOD-9604 targets the fat cells themselves. Limited human efficacy data compared to GLP-1 agonists.
Semaglutide
A medication that reduces appetite and helps your body lose weight by mimicking a natural gut hormone.
5-Amino-1MQ
A small molecule that blocks an enzyme responsible for fat storage — may support weight loss by shifting metabolism toward fat burning.
This compound is in early research stages. We do not currently offer it.
Looking for something similar? See what we offer for Weight Loss.
This compound is in early research stages. It has not been FDA-approved and may not be available through compounding pharmacies. The information below is for educational purposes only. Do not attempt to self-administer research compounds.